Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Think Research Corporation (V:THNK)

Business Focus: Software (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for THNK within the last 6 months
See all filings within the past 6 months

Company News

Sep 12, 2023 11:00 ET
Think Research is a Proud Technology Partner Supporting Ontario Ministry Of Health's One Stop Talk/Parlons maintenant Service for Child and Youth Mental Health
TORONTO, Sept. 12, 2023 /CNW/ - Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), a company focused on transforming healthcare through digital health software solutions, is pleased to announce that it is a proud technology partner supporting the Ontario Ministry of Health's roll-out of One Stop Talk/Parlons maintenant (OST/PM) service. Think's Digital Front Door Solution is essential for helping the Ministry of Health to simplify navigation and increase availability of mental health services for children and youth throughout Ontario. OST/PM is a new virtual and confidential
Read full article
Aug 29, 2023 07:00 ET
Think Research Corporation Announces Record Second Quarter 2023 Results
Record Q2 2023 revenue of $22.5 million and Adjusted EBITDA of $1.3 millionAnnual Recurring Revenue increased by 67% to $25.0 million as of the end of the quarterTORONTO, Aug. 29, 2023 /CNW/ - Think Research Corporation (TSXV: THNK) ("Think" or the "Company"),  a company focused on transforming healthcare through digital health software solutions, is pleased to announce Second Quarter 2023 results. The Company's Management Discussion and Analysis (MD&A) along with unaudited consolidated interim financial statements for Q2 2023 are available on SEDAR at and on Think's websit
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 2023615-33,481
Aug 31, 202334,09631,396
Aug 15, 20232,700-39,151
See Short Report

Business Summary

Sector:  Technology Industry:  Software

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.

See business summary



Search (past week) for $THNK.CA THNK.V

  • No tweets found